Accessibility Menu
 
Gelesis logo

Gelesis

(OTC) GLSHQ

Current Price$0.00
Market Cap$100
Since IPO (2020)-100%
5 Year-100%
1 Year+0%
1 Month-99%

Gelesis Financials at a Glance

Market Cap

$100

Revenue (TTM)

$12.14M

Net Income (TTM)

$51.67M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-317.39 (Low)

Price

$0.00

Volume

100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

GLSHQ News

No articles available.

GLSHQ: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gelesis

Industry

Biotechnology

Employees

100

CEO

Yishai Zohar

Headquarters

Boston, MA 02116, US

GLSHQ Financials

Key Financial Metrics (TTM)

Gross Margin

-7%

Operating Margin

-5%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

-2%

Return on Assets

-54%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

73.34M

Volume

100

Short Interest

0.00%

Avg. Volume

2.07K

Financials (TTM)

Gross Profit

$1.79M

Operating Income

$121.81M

EBITDA

$48.35M

Operating Cash Flow

$77.73M

Capital Expenditure

$9.12M

Free Cash Flow

$86.85M

Cash & ST Invst.

$7.41M

Total Debt

$62.26M

Gelesis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$1.11M

-87.7%

Gross Profit

$609.00K

-85.5%

Gross Margin

55.01%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$1.08

N/A

Employees

93

N/A

Net Income

$7.68M

+39.0%

EBITDA

$4.88M

+56.5%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$53.97M

-460.8%

Accounts Receivable

$9.56M

-32.2%

Inventory

$5.69M

-69.8%

Long Term Debt

$27.96M

-10.5%

Short Term Debt

$33.91M

+809.9%

Return on Assets

-53.99%

N/A

Return on Invested Capital

-2.31%

N/A

Free Cash Flow

$599.00K

+107.8%

Operating Cash Flow

$617.00K

+113.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GNBTGenerex Biotechnology Corporation
$0.00+0.00%
EPRSQEPIRUS Biopharmaceuticals, Inc.
$0.00-99.00%
GTHRGeneThera, Inc.
$0.00+0.00%
CRYOAmerican CryoStem Corporation
$0.00-99.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.15+0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$80.49-0.10%
IBITiShares Bitcoin Trust
$38.42+0.02%

Questions About GLSHQ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.